- info@anseaconsulting.com
- Singapore: +65 6956 6164
- Basel: +41 61 564 1420
Menu
To assess the APAC pricing and reimbursement landscape for the treatment of two rare
diseases and highlight bright spots and potential challenges
Undertook a market assessment of 12 APAC markets
Performed a deep-dive analysis involving product assessment, population needs,
health systems dynamics and regulatory access, competitor analysis, pricing and brand
revenue in each of the markets in scope
Opportunity size and prioritization assessment of the targeted markets in APAC
Comprehensive 12 countries overview with core indicators for market potential and barriers
The client has a stronger view of the market landscape and drivers, and a blueprint to individually navigate the 12 APAC markets
